Lindbrook Capital’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | $7.26K | Buy |
69
+6
| +10% | +$631 | ﹤0.01% | 1793 |
|
2024
Q4 | $6.75K | Hold |
63
| – | – | ﹤0.01% | 1845 |
|
2024
Q3 | $6.31K | Hold |
63
| – | – | ﹤0.01% | 1908 |
|
2024
Q2 | $5.31K | Buy |
63
+8
| +15% | +$674 | ﹤0.01% | 1965 |
|
2024
Q1 | $4.02K | Hold |
55
| – | – | ﹤0.01% | 1993 |
|
2023
Q4 | $3.93K | Buy |
+55
| New | +$3.93K | ﹤0.01% | 2012 |
|
2023
Q3 | – | Sell |
-20
| Closed | -$1.44K | – | 2780 |
|
2023
Q2 | $1.44K | Hold |
20
| – | – | ﹤0.01% | 2279 |
|
2023
Q1 | $1.47K | Buy |
+20
| New | +$1.47K | ﹤0.01% | 2360 |
|
2022
Q4 | – | Sell |
-93
| Closed | -$5K | – | 2939 |
|
2022
Q3 | $5K | Buy |
+93
| New | +$5K | ﹤0.01% | 1676 |
|
2020
Q2 | – | Sell |
-30
| Closed | -$1K | – | 1823 |
|
2020
Q1 | $1K | Hold |
30
| – | – | ﹤0.01% | 1493 |
|
2019
Q4 | $2K | Hold |
30
| – | – | ﹤0.01% | 1298 |
|
2019
Q3 | $2K | Sell |
30
-92
| -75% | -$6.13K | ﹤0.01% | 1271 |
|
2019
Q2 | $8K | Hold |
122
| – | – | ﹤0.01% | 950 |
|
2019
Q1 | $9K | Hold |
122
| – | – | ﹤0.01% | 922 |
|
2018
Q4 | $10K | Buy |
+122
| New | +$10K | ﹤0.01% | 820 |
|